RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Semaglutide, a glucagon like peptide-1 receptor agonist with cardiovascular benefits for management of type 2 diabetes.

Semaglutide, a glucagon like peptide-1 receptor agonist with cardiovascular benefits for management of type 2 diabetes.

Add to Collection
2022 Jun Others Fist_Author_Year_PM

Full Author : ['Mahapatra, Manoj Kumar', 'Karuppasamy, Muthukumar', 'Sahoo, Biswa Mohan']
Journal Title : Reviews in endocrine & metabolic disorders
Chapter : Section3
Journal Year : 2022
Cited by : Not Available

Semaglutide, a glucagon like peptide-1 (GLP-1) receptor agonist, is available as monotherapy in both subcutaneous as well as oral dosage form (first approved oral GLP-1 receptor agonist). It has been approved as a second line treatment option for better g.....

Keywords : ["glucagon like receptor agonist", "type diabetes", "cardiovascular benefit", "semaglutide", "management"]